Chung-Ang University Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT02970643
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

olanzapine (zyprexa) (1 trial)

palonosetron (aloxi) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2